Resources

Featured

Ending an epidemic: Prioritizing people who inject drugs in HCV elimination efforts
July 2018

Fuelled by political will, resources for cost-effective, evidence-based prevention programmes and revolutionary advances in hepatitis C virus (HCV) treatment, momentum is building towards halting a deadly global epidemic. Worldwide, an estimated 71 million people are living with hepatitis C, a blood- borne virus that infects liver cells.

English version

Spanish version / Versión en español

Russian version / Русская версия

Ending an epidemic: Prioritizing people who inject drugs in HCV elimination efforts

 

English version

Spanish version / Versión en español
Poner fin a una epidemia: Priorizando a las personas que se inyectan drogas en los esfuerzos para eliminar el virus de la hepatitis C

Russian version / Русская версия
Покончить с эпидемией: Приоритизация людей, употребляющих инъекционные наркотики, в усилиях по искоренению вирусного гепатита С